Procter & Gamble Health Limited (PGHL) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Procter & Gamble Health Limited stock ₹4,436, price ₹5,596, that is 20.7% below the price, quality 92 out of 100. Rating: overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Procter & Gamble Health Limited
PGHL · NSEExpensive (fair value 21% below the price) and price moving sideways, but strong company: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 12, 2026.
How to read this chart
60‑month range ₹3,484 – ₹6,919 · fair‑value band ₹2,923 – ₹6,485 · the ₹5,596 price screens above the ₹4,436 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 12, 2026.
Every Wednesday you see whether Procter & Gamble Health is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Procter & Gamble Health Limited manufactures and markets pharmaceuticals and chemical products in India and internationally. The company offers over-the-counter products, vitamins, minerals, and supplements.
Show moreShow less
It offers its products under the Polybion, Cosome, Evion, Neurobion, Nasivion, Livogen, and Seven Seas brands. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019.
Procter & Gamble Health Limited was incorporated in 1967 and is headquartered in Mumbai, India. Procter & Gamble Health Limited is a subsidiary of Procter & Gamble Overseas India B.V.
Stock analysis
Procter & Gamble Health Limited (PGHL) currently trades at ₹5,596, while our model-based Fair Value estimate is ₹4,436, 21% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ₹3,937 per share, and 0 of the 26 models we run sit above the ₹5,596 price.
Bear case: the Economic Profit group reads lowest at ₹1,367, and 26 of the 26 models stay below the price. Data coverage for this calculation is medium.
Scenario range: ₹2,923 (bear) to ₹6,485 (bull), the price of ₹5,596 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 92/100 (high quality), in the Healthcare sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Procter & Gamble Health Limited reported revenue of ₹14.1B in FY2025 versus ₹11.1B in FY2021, a compound +6.0%/yr. Reported net income was ₹3.3B in FY2025, compounding +14.2%/yr from FY2021.
Key figures
Market cap ₹92.9B (≈ $986M) Small · P/E ratio 26.0 · P/S ratio 6.48 · EPS (TTM) ₹215.19 · Dividend yield 3.7% · Net margin 24.9% · Return on equity 61.6% · Return on assets (EBIT) 60.6% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 88 out of 100 (low confidence).
What moves the price
The share trades about 19% below its 52-week high and 17% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −27% fair-value upside, at −21%, PGHL screens cheaper than that median.
Fair Value models
All 26 models by family
The fair value above starts from this blend and is adjusted for a year distorted by one-off effects.
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
PGHL screens overvalued: fair value 21% below the price. Compare with Merck KGaA →
Compare Procter & Gamble Health Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 604 stocks
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Return on assets by industry
- Fair value gap by industry
- Stock screener with 62 metrics
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Zoetis Inc ZTS | $83.82 | $113.53 | +35% | vs PGHL |
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥48.02 | ¥53.04 | +10% | vs PGHL |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,868 | ₹1,983 | +6% | vs PGHL |
| Haleon plc HLN | $9.17 | $8.47 | −8% | vs PGHL |
| Merck KGaA MRK | €149.70 | €108.83 | −27% | vs PGHL |
| Galderma Group GALD | CHF 191.00 | CHF 112.30 | −41% | vs PGHL |
| Takeda Pharmaceutical Company TAK | $21.43 | $11.20 | −48% | vs PGHL |
| Sandoz Group SDZ | CHF 84.60 | CHF 40.54 | −52% | vs PGHL |
| Teva Pharmaceutical Industries Limited TEVA | $44.50 | $20.74 | −53% | vs PGHL |
| Divi's Laboratories Limited DIVISLAB | ₹11,080 | ₹1,567 | −86% | vs PGHL |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Procter & Gamble Health Limited (PGHL) overvalued or undervalued?
What is the fair value of PGHL?
What is the quality score of PGHL?
What is the price target for Procter & Gamble Health Limited (PGHL)?
What is the Procter & Gamble Health Limited stock forecast for 2026?
What is the revenue of Procter & Gamble Health Limited (PGHL)?
Does Procter & Gamble Health Limited pay a dividend?
How much is the dividend of Procter & Gamble Health Limited (PGHL) and when is the ex-dividend date?
What growth is priced into Procter & Gamble Health Limited (PGHL)?
What discount rate (WACC) does the fair value of PGHL use?
What is a reverse DCF?
How much growth has Procter & Gamble Health Limited (PGHL) delivered so far?
How fast is the sector of Procter & Gamble Health Limited (PGHL) growing?
What is the free cash flow yield of Procter & Gamble Health Limited (PGHL)?
What is the intrinsic value of Procter & Gamble Health Limited (PGHL)?
Is Procter & Gamble Health Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of PGHL?
How much is Procter & Gamble Health Limited worth?
What do the bullish and bearish scenarios say about PGHL?
What is the P/E ratio of PGHL?
How solid is the balance sheet of Procter & Gamble Health Limited (PGHL)?
How far is PGHL from its 52-week high?
Which stocks are comparable to Procter & Gamble Health Limited?
Is Procter & Gamble Health Limited stock attractive at the current price?
How is the fair value of PGHL calculated?
Is it still worth investing in stocks now?
What is the share price of Procter & Gamble Health Limited (PGHL)?
What should I pay attention to with Procter & Gamble Health Limited right now?
Where does the earnings growth of Procter & Gamble Health Limited (PGHL) come from?
Key figures of Procter & Gamble Health Limited
How large is the market capitalisation of Procter & Gamble Health Limited (PGHL)?
What is the P/S ratio of Procter & Gamble Health Limited (PGHL)?
What are the earnings per share of Procter & Gamble Health Limited (PGHL)?
What is the dividend yield of Procter & Gamble Health Limited (PGHL)?
What is the net margin of Procter & Gamble Health Limited (PGHL)?
What is the return on equity of Procter & Gamble Health Limited (PGHL)?
What is the EBIT return on assets of Procter & Gamble Health Limited (PGHL)?
What is the operating margin of Procter & Gamble Health Limited (PGHL)?
How fast is revenue growing at Procter & Gamble Health Limited (PGHL)?
How fast are earnings growing at Procter & Gamble Health Limited (PGHL)?
How much net cash does Procter & Gamble Health Limited (PGHL) hold?
Watch Procter & Gamble Health Limited in the live analysis
One click puts Procter & Gamble Health Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.